PDCD1 and head and neck squamous cell carcinoma: In vivo lineage tracing revealed that AOH1996 reduced Bmi1+ CSCs in HNSCC, whereas the combination treatment of AOH1996 and anti-PD1 led to increased elimination of Bmi1+ CSCs (Fig. 4K).